Acyclovir EP Impurity Q
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Acyclovir EP Impurity Q

● Under Development

Catalogue No.:VL13023
CAS No.:N/A
Mol. Formula:C18H26N10O8
Mol. Weight:510.46

Additional information on Acyclovir EP Impurity Q

Parent drug

Acyclovir

IUPAC Name

2-Amino-9-(((2-hydroxyethoxy)methoxy)methyl)-1,9-dihydro-6H-purin-6-one compound with 2-amino-9-((2-(hydroxymethoxy)ethoxy)methyl)-1,9-dihydro-6H-purin-6-one (1:1)

Synonyms

N/A

Description

Acyclovir EP Impurity Q is a structurally related nucleoside impurity with formula C18H26N10O8 and molecular weight 510.46. Its composition indicates a heavily functionalized guanine-derived analogue, consistent with an oxidized or overacylated synthetic byproduct rather than a simple process residue. Such species may arise during multistep protection, glycosylation, or final deprotection sequences used in acyclovir manufacture. Because closely related purine impurities can affect assay specificity and impurity profiling, characterization typically requires reversed-phase LC coupled to high-resolution MS, often with MS/MS fragmentation support, and orthogonal LC-UV methods for trace-level resolution.

References

O’Brien, John J., and Deborah M. Campoli-Richards. “Acyclovir.” Drugs, vol. 37, no. 3, Mar. 1989, pp. 233–309, 10.2165/00003495-198937030-00002.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url